Research progress in Menin-MLL interaction and its inhibitors in MLL-rearranged leukemia
Acute leukemias caused by mixed lineage leukemia (MLL) gene rearrangements (MLL-r) are characterized by high invasiveness and a poor prognosis, with few specific treatment options available. MLL protein is essential in embryonic development and hematopoiesis. It exhibits histone methyltransferase ac...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Journal of Shanghai Jiao Tong University (Medical Science)
2024-10-01
|
| Series: | Shanghai Jiaotong Daxue xuebao. Yixue ban |
| Subjects: | |
| Online Access: | https://xuebao.shsmu.edu.cn/CN/10.3969/j.issn.1674-8115.2024.10.011 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846169455258763264 |
|---|---|
| author | FANG Xinyue SHI Lan XIA Siyi WANG Jiaxuan WU Yingli HE Kejun |
| author_facet | FANG Xinyue SHI Lan XIA Siyi WANG Jiaxuan WU Yingli HE Kejun |
| author_sort | FANG Xinyue |
| collection | DOAJ |
| description | Acute leukemias caused by mixed lineage leukemia (MLL) gene rearrangements (MLL-r) are characterized by high invasiveness and a poor prognosis, with few specific treatment options available. MLL protein is essential in embryonic development and hematopoiesis. It exhibits histone methyltransferase activity and can interact with various proteins through its functional domains, thus regulating downstream target gene expression through epigenetic modifications. MLL-r leads to the formation of MLL fusion proteins (MLL-FPs), in which the C-terminal is replaced by fusion partner proteins; over 100 such partner proteins have been identified to date. In numerous studies of the molecular mechanism, Menin serves as an important cofacter in the leukemogenesis of MLL-FPs and participates in forming the key complex when interacting with the N terminal of MLL protein, resulting in the disregulation of certain targeted genes, which makes the development of Menin-MLL inhibitors theoretically possible. To date, several small molecules have been identified that inhibit Menin-MLL interaction, including thienopyrimidine derivatives, piperidine derivatives, pyrimidine derivatives, and macrocyclic mimic peptides. Based on these prototypes, at least seven drugs are currently undergoing clinical evaluation, with some promising preliminary data regarding safety, tolerability, and efficacy. This review summarizes the structure and function of MLL, the mechanism of the occurrence of MLL-r leukemia, and current Menin-MLL inhibitors tested in MLL-r leukemia. |
| format | Article |
| id | doaj-art-f9d854c8ca9b48b2a80ea198221bb711 |
| institution | Kabale University |
| issn | 1674-8115 |
| language | zho |
| publishDate | 2024-10-01 |
| publisher | Editorial Office of Journal of Shanghai Jiao Tong University (Medical Science) |
| record_format | Article |
| series | Shanghai Jiaotong Daxue xuebao. Yixue ban |
| spelling | doaj-art-f9d854c8ca9b48b2a80ea198221bb7112024-11-13T03:13:33ZzhoEditorial Office of Journal of Shanghai Jiao Tong University (Medical Science)Shanghai Jiaotong Daxue xuebao. Yixue ban1674-81152024-10-0144101287129810.3969/j.issn.1674-8115.2024.10.0111674-8115（2024）10-1287-12Research progress in Menin-MLL interaction and its inhibitors in MLL-rearranged leukemiaFANG Xinyue0SHI Lan1XIA Siyi2WANG Jiaxuan3WU Yingli4HE Kejun5Faculty of Clinical Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai200025, ChinaFaculty of Clinical Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai200025, ChinaFaculty of Clinical Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai200025, ChinaFaculty of Clinical Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai200025, ChinaDepartment of Pathophysiology, Shanghai Jiao Tong University College of Basic Medical Sciences, Shanghai200025, ChinaPediatric Hematology and Oncology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai200092, ChinaAcute leukemias caused by mixed lineage leukemia (MLL) gene rearrangements (MLL-r) are characterized by high invasiveness and a poor prognosis, with few specific treatment options available. MLL protein is essential in embryonic development and hematopoiesis. It exhibits histone methyltransferase activity and can interact with various proteins through its functional domains, thus regulating downstream target gene expression through epigenetic modifications. MLL-r leads to the formation of MLL fusion proteins (MLL-FPs), in which the C-terminal is replaced by fusion partner proteins; over 100 such partner proteins have been identified to date. In numerous studies of the molecular mechanism, Menin serves as an important cofacter in the leukemogenesis of MLL-FPs and participates in forming the key complex when interacting with the N terminal of MLL protein, resulting in the disregulation of certain targeted genes, which makes the development of Menin-MLL inhibitors theoretically possible. To date, several small molecules have been identified that inhibit Menin-MLL interaction, including thienopyrimidine derivatives, piperidine derivatives, pyrimidine derivatives, and macrocyclic mimic peptides. Based on these prototypes, at least seven drugs are currently undergoing clinical evaluation, with some promising preliminary data regarding safety, tolerability, and efficacy. This review summarizes the structure and function of MLL, the mechanism of the occurrence of MLL-r leukemia, and current Menin-MLL inhibitors tested in MLL-r leukemia.https://xuebao.shsmu.edu.cn/CN/10.3969/j.issn.1674-8115.2024.10.011mll-rearranged leukemiamenintargeted therapymenin-mll inhibitor |
| spellingShingle | FANG Xinyue SHI Lan XIA Siyi WANG Jiaxuan WU Yingli HE Kejun Research progress in Menin-MLL interaction and its inhibitors in MLL-rearranged leukemia Shanghai Jiaotong Daxue xuebao. Yixue ban mll-rearranged leukemia menin targeted therapy menin-mll inhibitor |
| title | Research progress in Menin-MLL interaction and its inhibitors in MLL-rearranged leukemia |
| title_full | Research progress in Menin-MLL interaction and its inhibitors in MLL-rearranged leukemia |
| title_fullStr | Research progress in Menin-MLL interaction and its inhibitors in MLL-rearranged leukemia |
| title_full_unstemmed | Research progress in Menin-MLL interaction and its inhibitors in MLL-rearranged leukemia |
| title_short | Research progress in Menin-MLL interaction and its inhibitors in MLL-rearranged leukemia |
| title_sort | research progress in menin mll interaction and its inhibitors in mll rearranged leukemia |
| topic | mll-rearranged leukemia menin targeted therapy menin-mll inhibitor |
| url | https://xuebao.shsmu.edu.cn/CN/10.3969/j.issn.1674-8115.2024.10.011 |
| work_keys_str_mv | AT fangxinyue researchprogressinmeninmllinteractionanditsinhibitorsinmllrearrangedleukemia AT shilan researchprogressinmeninmllinteractionanditsinhibitorsinmllrearrangedleukemia AT xiasiyi researchprogressinmeninmllinteractionanditsinhibitorsinmllrearrangedleukemia AT wangjiaxuan researchprogressinmeninmllinteractionanditsinhibitorsinmllrearrangedleukemia AT wuyingli researchprogressinmeninmllinteractionanditsinhibitorsinmllrearrangedleukemia AT hekejun researchprogressinmeninmllinteractionanditsinhibitorsinmllrearrangedleukemia |